Covid-19 Impact on Global Native Bacterial Antigens Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Native Bacterial Antigens Revenue
1.4 Covid-19 Implications on Market by Pathogen Type
1.4.1 Global Native Bacterial Antigens Market Size Growth Rate by Pathogen Type: 2020 VS 2026
1.4.2 Inactivated Pathogen
1.4.3 Purified Pathogen
1.5 Market by Application
1.5.1 Global Native Bacterial Antigens Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Diagnostic Laboratories
1.5.4 Academic and Research Institutes
1.6 Coronavirus Disease 2019 (Covid-19): Native Bacterial Antigens Industry Impact
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Covid-19 Implications on Global Native Bacterial Antigens Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Native Bacterial Antigens Growth Trends by Regions
2.2.1 Native Bacterial Antigens Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Native Bacterial Antigens Historic Market Share by Regions (2015-2020)
2.2.3 Native Bacterial Antigens Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Native Bacterial Antigens Market Growth Strategy
2.3.6 Primary Interviews with Key Native Bacterial Antigens Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
3.1 Global Top Native Bacterial Antigens Players by Market Size
3.1.1 Global Top Native Bacterial Antigens Players by Revenue (2015-2020)
3.1.2 Global Native Bacterial Antigens Revenue Market Share by Players (2015-2020)
3.1.3 Global Native Bacterial Antigens Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Native Bacterial Antigens Market Concentration Ratio
3.2.1 Global Native Bacterial Antigens Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Native Bacterial Antigens Revenue in 2019
3.3 Native Bacterial Antigens Key Players Head office and Area Served
3.4 Key Players Native Bacterial Antigens Product Solution and Service
3.5 Date of Enter into Native Bacterial Antigens Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Pathogen Type (2015-2026)
4.1 Global Native Bacterial Antigens Historic Market Size by Pathogen Type (2015-2020)
4.2 Global Native Bacterial Antigens Forecasted Market Size by Pathogen Type (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
5.1 Global Native Bacterial Antigens Market Size by Application (2015-2020)
5.2 Global Native Bacterial Antigens Forecasted Market Size by Application (2021-2026)
6 North America Impact of COVID-19
6.1 North America Native Bacterial Antigens Market Size (2015-2020)
6.2 Native Bacterial Antigens Key Players in North America (2019-2020)
6.3 North America Native Bacterial Antigens Market Size by Pathogen Type (2015-2020)
6.4 North America Native Bacterial Antigens Market Size by Application (2015-2020)
7 Europe Impact of COVID-19
7.1 Europe Native Bacterial Antigens Market Size (2015-2020)
7.2 Native Bacterial Antigens Key Players in Europe (2019-2020)
7.3 Europe Native Bacterial Antigens Market Size by Pathogen Type (2015-2020)
7.4 Europe Native Bacterial Antigens Market Size by Application (2015-2020)
8 China Impact of COVID-19
8.1 China Native Bacterial Antigens Market Size (2015-2020)
8.2 Native Bacterial Antigens Key Players in China (2019-2020)
8.3 China Native Bacterial Antigens Market Size by Pathogen Type (2015-2020)
8.4 China Native Bacterial Antigens Market Size by Application (2015-2020)
9 Japan Impact of COVID-19
9.1 Japan Native Bacterial Antigens Market Size (2015-2020)
9.2 Native Bacterial Antigens Key Players in Japan (2019-2020)
9.3 Japan Native Bacterial Antigens Market Size by Pathogen Type (2015-2020)
9.4 Japan Native Bacterial Antigens Market Size by Application (2015-2020)
10 Southeast Asia Impact of COVID-19
10.1 Southeast Asia Native Bacterial Antigens Market Size (2015-2020)
10.2 Native Bacterial Antigens Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Native Bacterial Antigens Market Size by Type (2015-2020)
10.4 Southeast Asia Native Bacterial Antigens Market Size by Application (2015-2020)
11 India Impact of COVID-19
11.1 India Native Bacterial Antigens Market Size (2015-2020)
11.2 Native Bacterial Antigens Key Players in India (2019-2020)
11.3 India Native Bacterial Antigens Market Size by Type (2015-2020)
11.4 India Native Bacterial Antigens Market Size by Application (2015-2020)
12 Central & South America Impact of COVID-19
12.1 Central & South America Native Bacterial Antigens Market Size (2015-2020)
12.2 Native Bacterial Antigens Key Players in Central & South America (2019-2020)
12.3 Central & South America Native Bacterial Antigens Market Size by Type (2015-2020)
12.4 Central & South America Native Bacterial Antigens Market Size by Application (2015-2020)
13Key Players Profiles
13.1 The Native Antigen Company
13.1.1 The Native Antigen Company Company Details
13.1.2 The Native Antigen Company Business Overview and Its Total Revenue
13.1.3 The Native Antigen Company Native Bacterial Antigens Introduction
13.1.4 The Native Antigen Company Revenue in Native Bacterial Antigens Business (2015-2020))
13.1.5 The Native Antigen Company Recent Development and Reaction to COVID-19
13.2 Creative Diagnostics
13.2.1 Creative Diagnostics Company Details
13.2.2 Creative Diagnostics Business Overview and Its Total Revenue
13.2.3 Creative Diagnostics Native Bacterial Antigens Introduction
13.2.4 Creative Diagnostics Revenue in Native Bacterial Antigens Business (2015-2020)
13.2.5 Creative Diagnostics Recent Development and Reaction to COVID-19
13.3 Microbix Biosystems
13.3.1 Microbix Biosystems Company Details
13.3.2 Microbix Biosystems Business Overview and Its Total Revenue
13.3.3 Microbix Biosystems Native Bacterial Antigens Introduction
13.3.4 Microbix Biosystems Revenue in Native Bacterial Antigens Business (2015-2020)
13.3.5 Microbix Biosystems Recent Development and Reaction to COVID-19
13.4 SERION Immunologics
13.4.1 SERION Immunologics Company Details
13.4.2 SERION Immunologics Business Overview and Its Total Revenue
13.4.3 SERION Immunologics Native Bacterial Antigens Introduction
13.4.4 SERION Immunologics Revenue in Native Bacterial Antigens Business (2015-2020)
13.4.5 SERION Immunologics Recent Development and Reaction to COVID-19
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Details
13.5.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
13.5.3 Bio-Rad Laboratories Native Bacterial Antigens Introduction
13.5.4 Bio-Rad Laboratories Revenue in Native Bacterial Antigens Business (2015-2020)
13.5.5 Bio-Rad Laboratories Recent Development and Reaction to COVID-19
13.6 Enzo Life Sciences
13.6.1 Enzo Life Sciences Company Details
13.6.2 Enzo Life Sciences Business Overview and Its Total Revenue
13.6.3 Enzo Life Sciences Native Bacterial Antigens Introduction
13.6.4 Enzo Life Sciences Revenue in Native Bacterial Antigens Business (2015-2020)
13.6.5 Enzo Life Sciences Recent Development and Reaction to COVID-19
13.7 Jena Bioscience GmbH
13.7.1 Jena Bioscience GmbH Company Details
13.7.2 Jena Bioscience GmbH Business Overview and Its Total Revenue
13.7.3 Jena Bioscience GmbH Native Bacterial Antigens Introduction
13.7.4 Jena Bioscience GmbH Revenue in Native Bacterial Antigens Business (2015-2020)
13.7.5 Jena Bioscience GmbH Recent Development and Reaction to COVID-19
13.8 QED Bioscience
13.8.1 QED Bioscience Company Details
13.8.2 QED Bioscience Business Overview and Its Total Revenue
13.8.3 QED Bioscience Native Bacterial Antigens Introduction
13.8.4 QED Bioscience Revenue in Native Bacterial Antigens Business (2015-2020)
13.8.5 QED Bioscience Recent Development and Reaction to COVID-19
13.9 Ross Southern Laboratories
13.9.1 Ross Southern Laboratories Company Details
13.9.2 Ross Southern Laboratories Business Overview and Its Total Revenue
13.9.3 Ross Southern Laboratories Native Bacterial Antigens Introduction
13.9.4 Ross Southern Laboratories Revenue in Native Bacterial Antigens Business (2015-2020)
13.9.5 Ross Southern Laboratories Recent Development and Reaction to COVID-19
13.10 AROTEC Diagnostics
13.10.1 AROTEC Diagnostics Company Details
13.10.2 AROTEC Diagnostics Business Overview and Its Total Revenue
13.10.3 AROTEC Diagnostics Native Bacterial Antigens Introduction
13.10.4 AROTEC Diagnostics Revenue in Native Bacterial Antigens Business (2015-2020)
13.10.5 AROTEC Diagnostics Recent Development and Reaction to COVID-19
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Native Bacterial Antigens Key Market Segments
Table 2. Key Players Covered: Ranking by Native Bacterial Antigens Revenue
Table 3. Ranking of Global Top Native Bacterial Antigens Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Native Bacterial Antigens Market Size Growth Rate by Pathogen Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Inactivated Pathogen
Table 6. Key Players of Purified Pathogen
Table 7. COVID-19 Impact Global Market: (Four Native Bacterial Antigens Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Native Bacterial Antigens Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Native Bacterial Antigens Players to Combat Covid-19 Impact
Table 12. Global Native Bacterial Antigens Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Native Bacterial Antigens Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Native Bacterial Antigens Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Native Bacterial Antigens Market Share by Regions (2015-2020)
Table 16. Global Native Bacterial Antigens Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Native Bacterial Antigens Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Native Bacterial Antigens Market Growth Strategy
Table 22. Main Points Interviewed from Key Native Bacterial Antigens Players
Table 23. Global Native Bacterial Antigens Revenue by Players (2015-2020) (Million US$)
Table 24. Global Native Bacterial Antigens Market Share by Players (2015-2020)
Table 25. Global Top Native Bacterial Antigens Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Native Bacterial Antigens as of 2019)
Table 26. Global Native Bacterial Antigens by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Native Bacterial Antigens Product Solution and Service
Table 29. Date of Enter into Native Bacterial Antigens Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Native Bacterial Antigens Market Size by Pathogen Type (2015-2020) (Million US$)
Table 32. Global Native Bacterial Antigens Market Size Share by Pathogen Type (2015-2020)
Table 33. Global Native Bacterial Antigens Revenue Market Share by Pathogen Type (2021-2026)
Table 34. Global Native Bacterial Antigens Market Size Share by Application (2015-2020)
Table 35. Global Native Bacterial Antigens Market Size by Application (2015-2020) (Million US$)
Table 36. Global Native Bacterial Antigens Market Size Share by Application (2021-2026)
Table 37. North America Key Players Native Bacterial Antigens Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Native Bacterial Antigens Market Share (2019-2020)
Table 39. North America Native Bacterial Antigens Market Size by Pathogen Type (2015-2020) (Million US$)
Table 40. North America Native Bacterial Antigens Market Share by Pathogen Type (2015-2020)
Table 41. North America Native Bacterial Antigens Market Size by Application (2015-2020) (Million US$)
Table 42. North America Native Bacterial Antigens Market Share by Application (2015-2020)
Table 43. Europe Key Players Native Bacterial Antigens Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Native Bacterial Antigens Market Share (2019-2020)
Table 45. Europe Native Bacterial Antigens Market Size by Pathogen Type (2015-2020) (Million US$)
Table 46. Europe Native Bacterial Antigens Market Share by Pathogen Type (2015-2020)
Table 47. Europe Native Bacterial Antigens Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Native Bacterial Antigens Market Share by Application (2015-2020)
Table 49. China Key Players Native Bacterial Antigens Revenue (2019-2020) (Million US$)
Table 50. China Key Players Native Bacterial Antigens Market Share (2019-2020)
Table 51. China Native Bacterial Antigens Market Size by Pathogen Type (2015-2020) (Million US$)
Table 52. China Native Bacterial Antigens Market Share by Pathogen Type (2015-2020)
Table 53. China Native Bacterial Antigens Market Size by Application (2015-2020) (Million US$)
Table 54. China Native Bacterial Antigens Market Share by Application (2015-2020)
Table 55. Japan Key Players Native Bacterial Antigens Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Native Bacterial Antigens Market Share (2019-2020)
Table 57. Japan Native Bacterial Antigens Market Size by Pathogen Type (2015-2020) (Million US$)
Table 58. Japan Native Bacterial Antigens Market Share by Pathogen Type (2015-2020)
Table 59. Japan Native Bacterial Antigens Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Native Bacterial Antigens Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Native Bacterial Antigens Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Native Bacterial Antigens Market Share (2019-2020)
Table 63. Southeast Asia Native Bacterial Antigens Market Size by Pathogen Type (2015-2020) (Million US$)
Table 64. Southeast Asia Native Bacterial Antigens Market Share by Pathogen Type (2015-2020)
Table 65. Southeast Asia Native Bacterial Antigens Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Native Bacterial Antigens Market Share by Application (2015-2020)
Table 67. India Key Players Native Bacterial Antigens Revenue (2019-2020) (Million US$)
Table 68. India Key Players Native Bacterial Antigens Market Share (2019-2020)
Table 69. India Native Bacterial Antigens Market Size by Pathogen Type (2015-2020) (Million US$)
Table 70. India Native Bacterial Antigens Market Share by Pathogen Type (2015-2020)
Table 71. India Native Bacterial Antigens Market Size by Application (2015-2020) (Million US$)
Table 72. India Native Bacterial Antigens Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Native Bacterial Antigens Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Native Bacterial Antigens Market Share (2019-2020)
Table 75. Central & South America Native Bacterial Antigens Market Size by Pathogen Type (2015-2020) (Million US$)
Table 76. Central & South America Native Bacterial Antigens Market Share by Pathogen Type (2015-2020)
Table 77. Central & South America Native Bacterial Antigens Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Native Bacterial Antigens Market Share by Application (2015-2020)
Table 79. The Native Antigen Company Company Details
Table 80. The Native Antigen Company Business Overview
Table 81. The Native Antigen Company Product
Table 82. The Native Antigen Company Revenue in Native Bacterial Antigens Business (2015-2020) (Million US$)
Table 83. The Native Antigen Company Recent Development
Table 84. Creative Diagnostics Company Details
Table 85. Creative Diagnostics Business Overview
Table 86. Creative Diagnostics Product
Table 87. Creative Diagnostics Revenue in Native Bacterial Antigens Business (2015-2020) (Million US$)
Table 88. Creative Diagnostics Recent Development
Table 89. Microbix Biosystems Company Details
Table 90. Microbix Biosystems Business Overview
Table 91. Microbix Biosystems Product
Table 92. Microbix Biosystems Revenue in Native Bacterial Antigens Business (2015-2020) (Million US$)
Table 93. Microbix Biosystems Recent Development
Table 94. SERION Immunologics Company Details
Table 95. SERION Immunologics Business Overview
Table 96. SERION Immunologics Product
Table 97. SERION Immunologics Revenue in Native Bacterial Antigens Business (2015-2020) (Million US$)
Table 98. SERION Immunologics Recent Development
Table 99. Bio-Rad Laboratories Company Details
Table 100. Bio-Rad Laboratories Business Overview
Table 101. Bio-Rad Laboratories Product
Table 102. Bio-Rad Laboratories Revenue in Native Bacterial Antigens Business (2015-2020) (Million US$)
Table 103. Bio-Rad Laboratories Recent Development
Table 104. Enzo Life Sciences Company Details
Table 105. Enzo Life Sciences Business Overview
Table 106. Enzo Life Sciences Product
Table 107. Enzo Life Sciences Revenue in Native Bacterial Antigens Business (2015-2020) (Million US$)
Table 108. Enzo Life Sciences Recent Development
Table 109. Jena Bioscience GmbH Company Details
Table 110. Jena Bioscience GmbH Business Overview
Table 111. Jena Bioscience GmbH Product
Table 112. Jena Bioscience GmbH Revenue in Native Bacterial Antigens Business (2015-2020) (Million US$)
Table 113. Jena Bioscience GmbH Recent Development
Table 114. QED Bioscience Business Overview
Table 115. QED Bioscience Product
Table 116. QED Bioscience Company Details
Table 117. QED Bioscience Revenue in Native Bacterial Antigens Business (2015-2020) (Million US$)
Table 118. QED Bioscience Recent Development
Table 119. Ross Southern Laboratories Company Details
Table 120. Ross Southern Laboratories Business Overview
Table 121. Ross Southern Laboratories Product
Table 122. Ross Southern Laboratories Revenue in Native Bacterial Antigens Business (2015-2020) (Million US$)
Table 123. Ross Southern Laboratories Recent Development
Table 124. AROTEC Diagnostics Company Details
Table 125. AROTEC Diagnostics Business Overview
Table 126. AROTEC Diagnostics Product
Table 127. AROTEC Diagnostics Revenue in Native Bacterial Antigens Business (2015-2020) (Million US$)
Table 128. AROTEC Diagnostics Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Native Bacterial Antigens Market Share by Pathogen Type: 2020 VS 2026
Figure 2. Inactivated Pathogen Features
Figure 3. Purified Pathogen Features
Figure 4. Global Native Bacterial Antigens Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Diagnostic Laboratories Case Studies
Figure 7. Academic and Research Institutes Case Studies
Figure 8. Native Bacterial Antigens Report Years Considered
Figure 9. Global Native Bacterial Antigens Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Native Bacterial Antigens Market Share by Regions: 2020 VS 2026
Figure 11. Global Native Bacterial Antigens Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Native Bacterial Antigens Market Share by Players in 2019
Figure 14. Global Top Native Bacterial Antigens Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Native Bacterial Antigens as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Native Bacterial Antigens Revenue in 2019
Figure 16. North America Native Bacterial Antigens Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Native Bacterial Antigens Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Native Bacterial Antigens Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Native Bacterial Antigens Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Native Bacterial Antigens Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Native Bacterial Antigens Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Native Bacterial Antigens Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. The Native Antigen Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. The Native Antigen Company Revenue Growth Rate in Native Bacterial Antigens Business (2015-2020)
Figure 25. Creative Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Creative Diagnostics Revenue Growth Rate in Native Bacterial Antigens Business (2015-2020)
Figure 27. Microbix Biosystems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Microbix Biosystems Revenue Growth Rate in Native Bacterial Antigens Business (2015-2020)
Figure 29. SERION Immunologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. SERION Immunologics Revenue Growth Rate in Native Bacterial Antigens Business (2015-2020)
Figure 31. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Bio-Rad Laboratories Revenue Growth Rate in Native Bacterial Antigens Business (2015-2020)
Figure 33. Enzo Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Enzo Life Sciences Revenue Growth Rate in Native Bacterial Antigens Business (2015-2020)
Figure 35. Jena Bioscience GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Jena Bioscience GmbH Revenue Growth Rate in Native Bacterial Antigens Business (2015-2020)
Figure 37. QED Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. QED Bioscience Revenue Growth Rate in Native Bacterial Antigens Business (2015-2020)
Figure 39. Ross Southern Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Ross Southern Laboratories Revenue Growth Rate in Native Bacterial Antigens Business (2015-2020)
Figure 41. AROTEC Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. AROTEC Diagnostics Revenue Growth Rate in Native Bacterial Antigens Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed